Intelligent Bio Solutions (INBS) Cash from Investing Activities (2022 - 2025)
Intelligent Bio Solutions (INBS) recorded quarterly Cash from Investing Activities of -$14385.0 in Q1 2025, down 663.9% quarter-over-quarter from $2551.0 in Q1 2024, and down 663.9% on a YoY basis from $2551.0 in Q1 2024.
Intelligent Bio Solutions (INBS) Cash from Investing Activities (2022 - 2025) Analysis & Trends
Intelligent Bio Solutions' Cash from Investing Activities history runs 4 years deep, the most recent figure standing at -$14385.0 for Q1 2025.
- In Q1 2025, Cash from Investing Activities fell 663.9% year-over-year to -$14385.0; the TTM figure through Mar 2025 stood at -$19781.0 (up 90.87% YoY), while the FY2023 annual figure was -$694142.0, up 21.14% from the prior year.
- Cash from Investing Activities was -$14385.0 for Q1 2025 at Intelligent Bio Solutions, down from $2551.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $173803.0 in Q1 2023 to a low of -$703013.0 in Q2 2022.
- Historically, Cash from Investing Activities has averaged -$201284.1 across 4 years, with a median of -$181750.0 in 2023.
- The sharpest annual moves came in 2023 and 2025: Cash from Investing Activities surged 74.15% in 2023, then plunged 663.9% in 2025.
- A 4-year view of Cash from Investing Activities shows it stood at -$211304.0 in 2022, then increased by 13.99% to -$181750.0 in 2023, then jumped by 101.4% to $2551.0 in 2024, then slumped by 663.9% to -$14385.0 in 2025.
- The last three Cash from Investing Activities figures came in at -$14385.0 (Q1 2025), $2551.0 (Q1 2024), and -$181750.0 (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Intelligent Bio Solutions | 12.67 Mn | 11.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -14,385.00 |
| Mar 31, 2025 | -14,385.00 |
| Mar 31, 2024 | 2,551.00 |
| Mar 31, 2024 | 2,551.00 |
| Jun 30, 2023 | -181,750.00 |
| Jun 30, 2023 | -181,750.00 |
| Mar 31, 2023 | 173,803.00 |
| Mar 31, 2023 | 173,803.00 |
| Dec 31, 2022 | -211,304.00 |
| Dec 31, 2022 | -211,304.00 |
| Sep 30, 2022 | -474,891.00 |
| Sep 30, 2022 | -474,891.00 |
| Jun 30, 2022 | -703,013.00 |
| Jun 30, 2022 | -703,013.00 |